General Announcement::Press Release: BIOLIDICS' PARTNER IN CHINA TO OFFER LAB-DEVELOPED TESTS USING BIOLIDICS' PRODUCTS

Issuer & Securities

Issuer/ Manager
BIOLIDICS LIMITED
Securities
BIOLIDICS LIMITED - SGXE89830751 - 8YY
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
29-Mar-2019 17:35:54
Status
New
Announcement Sub Title
Press Release: BIOLIDICS' PARTNER IN CHINA TO OFFER LAB-DEVELOPED TESTS USING BIOLIDICS' PRODUCTS
Announcement Reference
SG190329OTHRLL7E
Submitted By (Co./ Ind. Name)
Lew Kwang Ping
Designation
Executive Director and Chief Executive Officer
Description (Please provide a detailed description of the event in the box below)
Please refer to attachment.

Attachments

Biolidics_China LDTs_press release_Final 29 Mar 2019.pdf
Total size =778K